Novel target sites in bacteria for overcoming antibiotic resistance

被引:38
作者
Black, MT [1 ]
Hodgson, J [1 ]
机构
[1] Novexel SA, F-93230 Romainville, France
关键词
bacterial genomics; target validation; compound libraries; lead identification; new class antibacterials;
D O I
10.1016/j.addr.2005.04.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Resistance to marketed antibiotics continues to increase. During the last 10 years some 200 bacterial genome sequences have become available, giving rise to expectations that genomics would provide a plethora of novel targets and hence a flood of new therapeutic agents. Contrary to some predictions the genomic effort has yet to yield a substantial number of novel class agents in clinical development. What are the reasons for the differences between expectations and reality? This article reviews what has been achieved in the exploitation of bacterial genomes for the discovery of novel antibacterials. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1528 / 1538
页数:11
相关论文
共 38 条
[1]   Systematic identification of essential genes by in vitro mariner mutagenesis [J].
Akerley, BJ ;
Rubin, EJ ;
Camilli, A ;
Lampe, DJ ;
Robertson, HM ;
Mekalanos, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8927-8932
[2]   The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of Gram-negative bacteria [J].
Alexeyev, MF .
BIOTECHNIQUES, 1999, 26 (05) :824-+
[3]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[4]   A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures [J].
Annis, DA ;
Nazef, N ;
Chuang, CC ;
Scott, MP ;
Nash, HM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (47) :15495-15503
[5]   New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity [J].
Beyer, D ;
Kroll, HP ;
Endermann, R ;
Schiffer, G ;
Siegel, S ;
Bauser, M ;
Pohlmann, J ;
Brands, M ;
Ziegelbauer, K ;
Haebich, D ;
Eymann, C ;
Brötz-Oesterhelt, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :525-532
[7]   Taking inventory: antibacterial agents currently at or beyond Phase 1 [J].
Bush, K ;
Macielag, M ;
Weidner-Wells, M .
CURRENT OPINION IN MICROBIOLOGY, 2004, 7 (05) :466-476
[8]   USE OF GENETIC-RECOMBINATION AS A REPORTER OF GENE-EXPRESSION [J].
CAMILLI, A ;
BEATTIE, DT ;
MEKALANOS, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2634-2638
[9]   Biochemical characterization of the first essential two-component signal transduction system from Staphylococcus aureus and Streptococcus pneumoniae [J].
Clausen, VA ;
Bae, WH ;
Throup, J ;
Burnham, MKR ;
Rosenberg, M ;
Wallis, NG .
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY, 2003, 5 (04) :252-260
[10]   Molecular cloning and expression of the sysB gene encoding an essential type I signal peptidase from Staphylococcus aureus [J].
Cregg, KM ;
Wilding, EI ;
Black, MT .
JOURNAL OF BACTERIOLOGY, 1996, 178 (19) :5712-5718